Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Revolution Medicines, Inc.

NASDAQ: RVMD · Life Sciences · 14 alerts · CIK 1628171

Share price
$166.87Close, Nov 16
Market cap
$36.1B
Shares outstanding
216.29MLatest SEC cover page
Sector
Life Sciences
Industry
Biological Products, (No Diagnostic Substances)SIC 2836

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Revolution Medicines, Inc. filings on SEC EDGAR ↗

4:32 PM ET 8-K
Loan & Debt

Revolution Medicines $250M Debt Financing with Royalty Pharma Development Funding, LLC

Revolution Medicines drew down a $250 million Tranche A senior secured term loan from Royalty Pharma following the FDA approval of RASONQUE. The loan bears interest at a floating rate of three-month Term SOFR plus 5.75% and is due in full on October 8, 2032. The company also elected not to exercise an option to sell an additional $250 million royalty interest to Royalty Pharma.

Value
$250M
Counterparty
Royalty Pharma Development Funding, LLC
Term
through Oct 2032

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.